DYN
Dyne Therapeutics, Inc.
Stock
$15.20−0.62 (−3.92%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $46M
- YoY, 2025
- 0.0%
- 5-year CAGR
- +47.4%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $46M | 0.0% |
| 2024 | $46M | +129.6% |
| 2023 | $20M | +31.6% |
| 2022 | $15M | −13.5% |
| 2021 | $18M | +166.2% |
| 2020 | $6.6M | +25,250.0% |
| 2019 | $26K | — |